Healthcare News: MedPAC suggests overhaul of Part B drug payment policy in June report

Article Overview

This news article covers Medicare Payment Advisory Commission (MedPAC) recommendations to revise Medicare Part B drug payment policy. It focuses on the Commission’s concerns about rising spending, pricing competition, and reimbursement structure, then outlines broad categories of proposed changes to the average sales price (ASP) framework and a new voluntary payment model discussed for future implementation. The article is relevant to providers, coders, revenue cycle professionals, and others tracking Medicare drug payment policy and CMS payment-model development.